Status:
RECRUITING
BoTox Into the Sternocleidomastoid Muscles (SCM)
Lead Sponsor:
Boston Medical Center
Collaborating Sponsors:
Evolus, Inc.
Conditions:
Neck Muscle Issue
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
Botulinum toxin injections have been used both in the face and neck for many years. However, injection into the sternocleidomastoid muscle (SCM) has only been done to treat neck spasms. In this study ...
Detailed Description
The specific study objectives are to determine if: * the neck circumference is decreased at 4 weeks after botulinum toxin (prabotulinumtoxinA-xvfs) injection. * patients can appreciate a difference i...
Eligibility Criteria
Inclusion
- Age eligible individual seeking a more feminine neck appearance
Exclusion
- Prior neuromodulator injections in the sternocleidomastoid muscles (SCM) within the past year
- Current anticoagulant use
- Body mass index (BMI) \>30
- Anticipation of significant weight gain or loss during the study period (e.g. patients taking or planning to take within the study period a semaglutide medication.)
- Prior allergy to botulinum toxin A
- Currently pregnant or breastfeeding
Key Trial Info
Start Date :
May 14 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06903975
Start Date
May 14 2025
End Date
March 1 2026
Last Update
June 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Spiegel Center
Newton, Massachusetts, United States, 02459